This grant funds innovative research to identify and reduce risk factors for Alzheimer's disease, requiring strong study design, preliminary data, and community collaboration, but does not allow clinical trials or animal research.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 22, 2026: Pre-Application (Preproposal) | September 24, 2026: Full Application | September 29, 2026: End of Application Verification
Funding Amounts: $4,000,000 total; up to $1M per award (single PI or combined for CIT Partnership); max 3 years
Summary: Supports transformative, non-incremental research to reduce risk and prevent Alzheimer's disease and related dementias; clinical research allowed, but clinical trials and animal research are prohibited.
Key Information: Community collaboration required for projects prospectively enrolling human subjects; preliminary data required.
This opportunity supports robust, well-designed research projects that drive transformative advancements in reducing risk and preventing the development of Alzheimer’s disease (AD) and Alzheimer’s disease related dementias (ADRD). Funded by the Congressionally Directed Medical Research Programs (CDMRP) under the Department of Defense, the award is designed to accelerate impactful solutions, focusing on risk factor knowledge and risk reduction strategies. The program encourages both new and established collaborations, including a Career Initiation or Transition (CIT) Partnership Option for multi-PI projects.
Distinctive features include: